Fine Foods & Pharmaceuticals N.T.M. S.p.A. is an integrated contract development and manufacturing organization (CDMO) operating in the pharmaceutical, nutraceutical, cosmetic, and medical device sectors. The company provides development and production services for food supplements, pharmaceuticals, and biocides, supporting clients in achieving growth objectives through scientific rigor and process efficiency. Its operations span multiple production sites in Italy, serving customers in the healthcare and consumer goods industries.

Summarised from the company's own disclosures, fiscal year ended Dec 2025

Industry Drug Manufacturers - Specialty & Generic Homepage finefoods.it
Sector Healthcare IR page finefoods.it
Tags
contract manufacturing, pharmaceuticals, food supplements, cosmetics, medical devices, biocides, cdmo
Press page finefoods.it/en/press-releases

Metrics

Valuation  
Market cap —
Market cap (USD) —
P/E —
PEG —
P/BV —
P/S —
P/OCF —
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE 7.6%
ROI 4.9%
ROIC 5.9%
Profit margin 4.0%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y No
Revenue up 5y —
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock Yes
Diluting (TTM) —
Debt/Equity 54.2%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 42
Quality score 36.4%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Revenue 253.463M 245.07M 252.907M 208.32M 195.245M
Net profit 10.097M 8.156M -3.522M -9.501M -1.427M
Free cash flow -2.866M 11.961M 411.864K -11.338M -20.676M

Filed figures

Figure Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (EUR) — 29.4M 39.3M 38.1M 37.5M 36.6M
↳ YoY growth +33.7% -3.3% -1.4% -2.5%
Borrowings, current (EUR) — 68.3M 39.9M 55.3M 18.4M 12.8M
Borrowings, non-current (EUR) — 38.6M 77.6M 9.73M 35M 72.7M
Bonds payable (EUR) — 6.63M 3.32M 0.00 — —
Lease liabilities (EUR) — 3.91M 2.87M 1.39M 1.17M 1.29M
Cash and deposits (EUR) 3.34M 17.1M 10.2M 19M 19.2M 38.9M
Intangible assets (EUR) — 2.34M 1.78M 1.63M 1.56M 1.92M
Right-of-use assets (EUR) — 6.41M 5.16M 3.17M 2.91M 2.89M
Net debt (borrowings + leases - cash) (EUR) — 93.7M 110M 47.4M 35.3M 47.9M
Cash flow detail
Operating cash flow (EUR) — -5.83M 3.69M 18.5M 45.9M 31.8M
Purchases of property, plant and equipment (EUR) — -14.8M -15M -18.1M -33.9M -34.6M
Purchases of intangible assets (EUR) — -1.07M -957,395 -741,615 -838,323 -1.37M
Change in receivables (cash effect) (EUR) — 0.00 3.27M 0.00 292,083 741,491
Change in inventories (cash effect) (EUR) — -9.99M -5.94M -2.45M 10.3M -4.69M
Change in payables (cash effect) (EUR) — 2M 918,351 -1.08M 4.19M -203,173
Dividends paid (cash effect) (EUR) — -3.21M -3.87M -2.45M -2.94M -3.43M
Share buybacks (cash effect) (EUR) — -7.18M -870,796 -340,575 -118,327 -4.58M
Interest paid (cash effect) (EUR) — -712,535 -2.16M -4.55M -2.74M -2.78M
Income taxes paid (cash effect) (EUR) — 5.22M 0.00 0.00 1.26M 1.14M
Operating cash flow before change in receivables (EUR) — -5.83M 421,414 18.5M 45.6M 31M
Free cash flow (OCF - PPE - intangibles) (EUR) — -21.7M -12.3M -329,751 11.1M -4.24M
Income detail
Total comprehensive income (EUR) — -1.44M -9.22M -3.55M 8.17M 10.2M
Reported Apr 4, 2023 Apr 4, 2023 Apr 4, 2023 Sep 24, 2025 Sep 24, 2025 Apr 7, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Comunicazione Internal Dealing Bull 0 Bear 0 Routine

Prompts

Fine Foods & Pharmaceuticals N.T.M. S.p.A. (ticker FF), listed in Italy.

ETFs Holding Fine Foods & Pharmaceuticals N.T.M. S.p.A.

ETF Weight in ETF Shares Market value As of
AVDV 0.00% 62 $ 375.04 Nov 16, 2026